Chapel Hill, NC, United States of America

Klim King

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Klim King: Innovator in Pharmaceutical Compounds

Introduction

Klim King is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of sexual dysfunction treatments. With a total of 4 patents to his name, King is recognized for his innovative approaches to medical challenges.

Latest Patents

Among his latest patents are the delta opioid receptor agonist compounds. These compositions and methods are designed for the treatment of sexual dysfunctions. Specifically, they involve administering a pharmaceutical composition comprising a delta opioid receptor agonist in an amount effective to delay the onset of ejaculation during sexual stimulation. This innovative approach aims to enhance the quality of life for individuals facing such challenges.

Career Highlights

Klim King is currently associated with Versi Group, LLC, where he continues to develop and refine his groundbreaking ideas. His work has garnered attention in the pharmaceutical industry, showcasing his commitment to improving therapeutic options for patients.

Collaborations

Klim collaborates with talented individuals such as Kwen-Jen Chang and Kestutis P Biciunas. These partnerships enhance the innovative potential of his projects and contribute to the advancement of their shared goals.

Conclusion

Klim King's contributions to the field of pharmaceuticals, particularly through his patents on delta opioid receptor agonist compounds, highlight his role as an influential inventor. His work not only addresses critical medical issues but also paves the way for future innovations in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…